FATE
Fate Therapeutics Inc.
$1.23
+$0.04(+3.36%)
51
Overall
60
Value
58
Tech
36
Quality
Market Cap
$137.24M
Volume
1.67M
52W Range
$0.66 - $1.94
Target Price
$4.94
EPS Estimates Overview
| Current Quarter | $-0.27 | Next Quarter | $-0.3 |
| Current Year | $-1.15 | Next Year | $-1.16 |
| QoQ Growth | -11.1% | YoY Growth | -0.9% |
| 3Y EPS CAGR | +9.9% | Target Price | $4.94 |
| Consensus | Buy | Upside | +301.6% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FATE | $1.23 | +3.4% | 1.67M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |